Patel Manesh R, Chen Anita Y, Peterson Eric D, Newby L Kristin, Pollack Charles V, Brindis Ralph G, Gibson C Michael, Kleiman Neal S, Saucedo Jorge F, Bhatt Deepak L, Gibler W Brian, Ohman E Magnus, Harrington Robert A, Roe Matthew T
Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA.
Am Heart J. 2006 Oct;152(4):641-7. doi: 10.1016/j.ahj.2006.02.035.
Unlike ST-segment elevation myocardial infarction, the degree of stenosis and physiology of ischemia varies in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The prevalence, predictors, and outcomes of patients with NSTEMI who lack significant epicardial coronary artery disease (CAD) in routine clinical practice remain poorly characterized. We sought to determine the prevalence, predictors, and outcomes of patients with NSTEMI and insignificant CAD.
We analyzed 38301 patients with NSTEMI in the CRUSADE quality improvement initiative who underwent cardiac catheterization to determine the prevalence and factors associated with insignificant CAD (all coronary stenoses <50%) and inhospital outcomes for patients with and without CAD. A multivariable model was used to determine the factors associated with insignificant CAD.
A total of 3306 (8.6%) of 38301 patients had insignificant CAD. The strongest multivariable predictors of insignificant CAD were female sex (odds ratio 2.8, 95% CI 2.6-3.1), younger age (odds ratio per 10-year decrease 1.5, 95% CI 1.5-1.6), and lack of current/recent smoking (odds ratio 1.9, 95% CI 1.7-2.0). Inhospital rates of death were 0.65% for patients with insignificant CAD compared with 2.36% for patients with CAD (P < .0001).
Insignificant CAD is present in 9% of patients with NSTEMI and is associated with a low incidence of adverse outcomes. The strongest predictors of insignificant CAD are female sex and younger age. These findings underscore the need for research to understand the pathophysiology of myocardial infarction in this population.
与ST段抬高型心肌梗死不同,非ST段抬高型心肌梗死(NSTEMI)患者的狭窄程度和缺血生理学存在差异。在常规临床实践中,缺乏显著心外膜冠状动脉疾病(CAD)的NSTEMI患者的患病率、预测因素和结局仍未得到充分描述。我们试图确定NSTEMI且CAD不显著患者的患病率、预测因素和结局。
我们分析了CRUSADE质量改进计划中38301例接受心脏导管检查的NSTEMI患者,以确定CAD不显著(所有冠状动脉狭窄<50%)的患病率和相关因素,以及有和无CAD患者的住院结局。使用多变量模型确定与CAD不显著相关的因素。
38301例患者中共有3306例(8.6%)CAD不显著。CAD不显著的最强多变量预测因素为女性(比值比2.8,95%可信区间2.6-3.1)、年龄较轻(每降低10岁比值比1.5,95%可信区间1.5-1.6)和目前/近期无吸烟(比值比1.9,95%可信区间1.7-2.0)。CAD不显著患者的住院死亡率为0.65%,而CAD患者为2.36%(P<.0001)。
9%的NSTEMI患者存在CAD不显著情况,且不良结局发生率较低。CAD不显著的最强预测因素为女性和年龄较轻。这些发现强调了开展研究以了解该人群心肌梗死病理生理学的必要性。